DPHARM 2025: What We Heard, What We Saw The 2025 edition of the Disruptive Innovations to Advance Clinical Trials (DPHARM) conference brought together a global community of clinical research leaders, sponsors, CROs, consultants, and technology innovators.For Mushroom Solutions, it was more than just an opportunity to showcase our automation-first platforms.
AI in Patient Recruitment: Sponsor Roadmap for Faster, Smarter Studies Recruitment challenges are not new — but they’re getting more expensive. Industry data shows that nearly 86% of international trials miss their recruitment targets within expected timelines, and delays of just one month can cost sponsors anywhere from $600,000 to
Generative AI for Clinical Trial Protocol Development: From Drafting to eProtocols Protocol development for clinical trials can slow down due to the growing complexity of modern trials—spanning multi-site operations, precision medicine demands, and diverse patient recruitment. Research teams typically spend 160–220 hours developing a single protocol, coordinating across multiple stakeholders
AI Powered Real Time Solutions: Mushroom Solutions Unveils New Strategy for Driving Automation in Clinical Trial Operations In an age where speed and efficiency are essential to success, the healthcare industry, particularly clinical trial operations, has been striving for faster, more accurate, and cost-effective processes. The DEA registrant base today
Decentralized Clinical Trials: The New Standard in Clinical Research It takes 12 years on average for a new drug to gain market approval from the preclinical stage and costs varying from $1-2.8 billion. Traditional clinical trials have been hampered by systemic challenges, from patient recruitment and retention to the geographic and
Optimizing Clinical Trial Budgeting: How AI-Powered CTOps by Mushroom Solutions Eliminates Hidden Costs and Accelerates Timelines Clinical research sites often encounter numerous financial challenges due to hidden costs that aren’t covered by standard study budgets. These additional expenses, ranging from administrative overheads to unforeseen regulatory requirements, can put a strain
How CMC Automation with AI Is Transforming Regulatory Reporting According to McKinsey, CMC “has a rare opportunity to reimagine its role and find innovative ways to improve and accelerate drug development.” CMC (chemistry, manufacturing, and controls) also known as Pharma Technical Development, develops processes and methods for producing safe and
Advanced Coverage Analysis with CTOps: Addressing Key Challenges for Sites and CROs In the clinical trials industry, ensuring that coverage analysis meets audit standards is critical. Coverage analysis, which involves determining whether the procedures performed during a clinical trial are covered by the sponsor’s insurance, plays a key role in
Is your regulatory team ready for the next FDA Deficiency Letters? FDA’s Center for Devices and Radiological Health (CDRH) reports over 55% of 510(k) submissions receive at least one Additional Information or Deficiency Letter—often due to missing data, unclear testing, or labeling issues. Across the product lifecycle, from preclinical to
